Additional provisional patent application, strengthens IP portfolio of therapeutics for the treatment of mild traumatic brain injuries (mTBI) with PTSD or PTSD alone. Vancouver, British Columbia–(Newsfile...
Vancouver, British Columbia–(Newsfile Corp. – July 23, 2020) – GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) (“GreenStar” or the “Company“), is pleased to announce that...
Strategic acquisition by GreenStar to add innovative company focused on the development of effective therapeutics using psychedelic medicine Vancouver, British Columbia–(Newsfile Corp. – July 21, 2020)...
Vancouver, British Columbia–(Newsfile Corp. – July 20, 2020) – GreenStar Biosciences Corp. (CSE: GSTR) (OTC Pink: GTSIF) (“GreenStar” or the “Company“), is pleased to announce that...
Eleusian Biosciences CEO, Jonathan Gilbert, will speak at the Peak Asset Management’s Webinar on Thursday June 18th at 7:30PST. GreenStar recently announced non-binding LOI with Eleusian...
Strategic acquisition by GreenStar to add innovative company focused on the development of effective therapeutics using psychedelic medicine Vancouver, British Columbia–(Newsfile Corp. – June 16, 2020)...
Vancouver, British Columbia–(Newsfile Corp. – May 25, 2020) – GreenStar Biosciences Corp. (CSE: GSTR) (“GreenStar” or the “Company”), announces it has granted stock options to acquire...
Vancouver, British Columbia–(Newsfile Corp. – April 17, 2020) – GreenStar Biosciences Corp. (CSE: GSTR) (“GreenStar” or the “Company”), announced today the resignation of Faizaan Lalani from...